FIGS Balansräkning Hälsa
Finansiell hälsa kriterier kontrolleras 6/6
FIGS har ett totalt eget kapital på $437.5M och en total skuld på $0.0 vilket ger sin skuldsättningsgrad till 0%. Dess totala tillgångar och totala skulder är $580.0M respektive $142.5M. FIGS s EBIT är $38.1M vilket gör dess räntetäckningsgrad -4.4. Den har kontanter och kortsiktiga investeringar på $300.8M.
Viktig information
0%
Skuldsättning i förhållande till eget kapital
US$0
Skuld
| Räntetäckningsgrad | -4.4x |
| Kontanter | US$300.85m |
| Eget kapital | US$437.46m |
| Summa skulder | US$142.53m |
| Totala tillgångar | US$580.00m |
Nya uppdateringar om finansiell hälsa
Inga uppdateringar
Recent updates
FIGS: International Expansion And Q4 Execution Are Expected To Sustain Upside Potential
Analysts have lifted the FIGS fair value estimate from $20.00 to $22.00, reflecting higher modeled revenue growth, a richer future P/E multiple, and Street research that points to momentum following recent earnings and international expansion commentary. Analyst Commentary Recent Street commentary around FIGS has turned more constructive, with several bullish analysts adjusting their price targets higher and revisiting their views after the latest quarterly update.
FIGS: International Expansion And Margin Recovery Efforts Will Drive Upside Potential
Narrative Update on FIGS The updated analyst price target for FIGS reflects a modest recalibration in the model inputs. Recent Street research citing Q4 outperformance, improving profitability and customer trends, and longer term opportunities around international expansion and scaling revenue helps explain why analysts continue to refine their $8 to $20 target range for the stock.FIGS: International Expansion And Margin Recovery Efforts Will Likely Cap Near Term Upside
Narrative Update on FIGS The analyst fair value estimate for FIGS has moved from $9.81 to $16.31 as analysts factor in a series of higher price targets and upgrades that highlight international expansion, margin recovery efforts, and what they describe as sustained recovery and strong momentum following recent Q4 results. Analyst Commentary Recent research on FIGS centers on how the company executes on growth opportunities while working to restore profitability metrics, with price target changes reflecting different views on how quickly that balance can be achieved.FIGS: Q4 Execution And Specialty Retail Tailwinds Are Expected To Drive Upside
The analyst fair value estimate for FIGS has increased to $20.00 from $15.00, as analysts point to Q4 earnings strength, improved profitability assumptions, and confidence that the company’s platform can support higher long term revenue potential. Analyst Commentary Recent research on FIGS has turned more constructive, with several bullish analysts revising their fair value views higher after the latest Q4 print and updated outlook.FIGS: Hold On To A Uniquely Positioned Company
Mar 06FIGS: Higher Multiple Assumptions Will Likely Limit Future Share Price Upside
Analysts have nudged their price expectations for FIGS higher, with a modest lift in fair value and future P/E assumptions helping to raise the average price target by about $0.50 as they factor in slightly stronger revenue growth and profit margin potential. Analyst Commentary Recent Street commentary around FIGS points to a mixed but generally constructive stance, with modest price target increases set against ongoing questions about execution and sector risks.
FIGS: Demand Uncertainty In Specialty Retail Will Constrain Future Share Performance
Analysts have raised their FIGS fair value estimate from about $4.00 to roughly $6.20 per share. This reflects updated assumptions for revenue growth, profit margins, and the future P/E multiple that are in line with recent price target increases from firms such as Morgan Stanley, Barclays, and Roth Capital.FIGS: Raised Outlook Will Rely On Specialty Retail Tailwinds Into 2026
Narrative Update Analysts have inched up their price targets on FIGS into the high single digit to low double digit US$ range, citing recent research that points to more constructive views on specialty retail through 2026 and firm specific discussions that suggest ongoing business momentum. At the same time, our model keeps fair value steady at US$15.00, with slightly higher revenue growth, margin and future P/E assumptions.FIGS: Upgraded Outlook Hinges On Strong Brand And Healthcare Apparel Demand
Analysts have lifted their FIGS fair value estimate from US$8.00 to US$15.00, reflecting updated assumptions for revenue growth, profit margins and future P/E, along with a series of recent price target increases from Barclays, Roth Capital, Morgan Stanley, Goldman Sachs and BTIG. Analyst Commentary Recent Street research around FIGS has leaned more constructive, with several bullish analysts lifting price targets and initiating positive coverage.FIGS: Reduced Discounting Will Likely Cap Upside Despite Recent Business Momentum
Analysts have modestly lowered our FIGS fair value estimate to approximately $9.17 per share from about $9.53, even as they raise price targets into the mid single to low double digits. They cite stronger than expected post Q3 momentum, improving demand trends, and a richer future earnings multiple outlook, despite slightly softer long term growth and margin assumptions.FIGS: Recent Momentum Will Likely Fade As Reduced Discounting Limits Upside
Our FIGS fair value estimate increases to $9.53 from $8.78 as analysts lift price targets following stronger than expected Q3 results, sustained business momentum signals, and a more constructive view on the brand's long term earnings power. Analyst Commentary Street research on FIGS has turned more constructive overall, with several firms lifting price targets and initiating positive coverage following the company’s strong Q3 performance and improving demand indicators.FIGS: Share Price Will Likely Reflect Limited Upside Amid Market Caution
Analysts have raised their fair value estimate for FIGS from $7.74 to $8.78, citing stronger than expected business momentum, improved revenue growth expectations, and expanding profit margins. Analyst Commentary Recent research coverage of FIGS has provided a mix of constructive insights and measured caution as analysts adjust their expectations.FIGS: Future Competitive Pressures Will Likely Limit Further Upside
FIGS’ analyst price target has increased from $6.74 to $7.74 per share. Analysts point to stronger revenue growth expectations and positive trends within the healthcare apparel sector, which support the revised outlook.There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 28% Price Jump
Nov 11
FIGS: High Market Expectations May Limit Upside As Momentum Slows
Analysts have slightly reduced their price target for FIGS, lowering it from $6.74 to $6.74. The adjustment reflects steady business fundamentals and persistent confidence in the brand's strong positioning within the healthcare apparel market.Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
Analysts have raised their price target for FIGS from $6.42 to $6.74, citing ongoing strength in U.S. healthcare apparel demand and a solid, debt-free balance sheet as supporting factors for the positive adjustment. Analyst Commentary Recent analyst coverage of FIGS has highlighted both encouraging trends and ongoing areas of caution regarding the company's growth trajectory and valuation.Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success
The notable upward revision in FIGS' fair value reflects improved consensus revenue growth expectations, more than offsetting the impact of a higher discount rate, resulting in an increased analyst price target from $4.86 to $5.85. What's in the News FIGS, Inc.There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 35% Price Jump
Jun 30It Looks Like FIGS, Inc.'s (NYSE:FIGS) CEO May Expect Their Salary To Be Put Under The Microscope
May 29Subdued Growth No Barrier To FIGS, Inc. (NYSE:FIGS) With Shares Advancing 40%
May 09Is Now The Time To Look At Buying FIGS, Inc. (NYSE:FIGS)?
May 03FIGS, Inc.: Recommending A Hold Despite Tailwinds
Apr 24FIGS' (NYSE:FIGS) Soft Earnings Don't Show The Whole Picture
Mar 06Figs, Inc. - Slow Growth Is Still Growth
Mar 06Be Wary Of FIGS (NYSE:FIGS) And Its Returns On Capital
Jan 30FIGS: Enter A White Knight?
Dec 12FIGS Back To Q1 Prices, But The Name Is Still A Hold
Nov 13The Price Is Right For FIGS, Inc. (NYSE:FIGS) Even After Diving 26%
Nov 10FIGS (NYSE:FIGS) May Have Issues Allocating Its Capital
Oct 18If EPS Growth Is Important To You, FIGS (NYSE:FIGS) Presents An Opportunity
Oct 03FIGS, Inc.: Growth Potentially Inflecting Upwards
Oct 03At US$5.61, Is FIGS, Inc. (NYSE:FIGS) Worth Looking At Closely?
Sep 18
Tactical Partnerships And Innovations Propel Brand Expansion And Financial Growth
The partnership with Team USA and innovative product lines like Flare ScrubLegging highlight brand visibility enhancement and market expansion efforts.FIGS Q2 2024 Shows Growth At The Expense Of Margins. The Stock Is Still Overpriced
Sep 05FIGS, Inc. (NYSE:FIGS) Shares Could Be 32% Below Their Intrinsic Value Estimate
Aug 06Capital Allocation Trends At FIGS (NYSE:FIGS) Aren't Ideal
Jul 19Analys av finansiell ställning
Kortfristiga skulder: FIGS s kortfristiga tillgångar ( $447.3M ) överstiger dess kortfristiga skulder ( $90.5M ).
Långfristiga skulder: FIGS s kortfristiga tillgångar ( $447.3M ) överstiger dess långfristiga skulder ( $52.0M ).
Skuld till eget kapital Historik och analys
Skuldnivå: FIGS är skuldfri.
Minska skulden: FIGS har inte haft några skulder de senaste 5 åren.
Skuldtäckning: FIGS har ingen skuld, därför behöver den inte täckas av operativt kassaflöde.
Räntetäckning: FIGS har inga skulder, därför är täckning av räntebetalningar inget problem.
Balansräkning
Upptäck friska företag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/01 09:43 |
| Aktiekurs vid dagens slut | 2026/05/01 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
FIGS, Inc. bevakas av 14 analytiker. 8 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Adrienne Yih-Tennant | Barclays |
| Robert Drbul | BTIG |
| Brooke Roach | Goldman Sachs |